Key facts
- This page summarizes Jessica Meng's Form 4 filing for CareDx, Inc. (CDNA).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 02 Jul 2026, 16:01.
Jessica Meng - 01 Jul 2026 Form 4 Insider Report for CareDx, Inc. (CDNA)
- Reporting relationship
- Chief Commercial Officer
- Issuer ticker
- CDNA
- Reported as of
- 01 Jul 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 02 Jul 2026, 16:01:38 UTC
- Prior SEC filing
- 03 Apr 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jeffrey Adam Novack, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Jessica Meng filed Form 4 for CareDx, Inc. (CDNA) on 02 Jul 2026.
Change
- Previous filing in this sequence was filed on 03 Apr 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0002036499
Primary reporting owner
Meng Jessica
- Relationship
- Chief Commercial Officer
- Address
- C/O CAREDX, INC., 8000 MARINA BLVD, 4TH FLOOR, BRISBANE
- Signature
- /s/ Jeffrey Adam Novack, Attorney-in-Fact
- Signature date
- 02 Jul 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CDNA
transaction
Common Stock
Tax liability
- Transaction value
- Shares
- -2,411
- Change %
- -1.4%
- Price
- $29.25*
- Shares after
- 168,287
- Date
- 01 Jul 2026
- Ownership
- Direct
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.
Footnote F2
Includes 1,306 shares acquired under the Issuer's Employee Stock Purchase Plan on June 30, 2026.